Contrary to prior data, this study shows that neither eosinophils nor STAT6-mediated IL-4/IL-13 signaling contribute ...

Buloxibutid is a first-in-class angiotensin II type 2 (AT2) receptor agonist that activates ... Approval and Priority Review. The Phase 2b ASPIRE trial to assess the safety and efficacy of ...

(G) Gastric adenocarcinoma, surgical resection from primary lesion. (H) Tumor cells show strong (3+) membrane staining (arrows) with FGFR2b. FGFR2b, fibroblast growth factor receptor 2 isoform IIIb; H ...